Regional hyperthermic perfusion with cisplatin following surgery for malignant melanoma of the extremities
- 30 April 1996
- journal article
- research article
- Published by Elsevier in The American Journal of Surgery
- Vol. 171 (4) , 416-420
- https://doi.org/10.1016/s0002-9610(97)89621-3
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Regional Chemotherapy for Melanoma A 35-Year ExperienceAnnals of Surgery, 1994
- Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugsWorld Journal of Surgery, 1992
- Loco-regional primary and recurrent melanoma: III. Update of natural history and non-systemic treatments (1980–1987)Cancer Treatment Reviews, 1988
- Pharmacokinetics, toxicity, and short-term results of cisplatin hyperthermic isolated limb perfusion for soft-tissue sarcoma and melanoma of the extremitiesThe American Journal of Surgery, 1988
- Effective management of extremity cancers using cisplatin and etoposide in isolated limb perfusionsJournal of Surgical Oncology, 1987
- Isolation perfusion with cisplatin for malignant melanoma of the limbsCancer, 1987
- A Prospective Randomized Study of Regional Extremity Perfusion in Patients with Malignant MelanomaAnnals of Surgery, 1984
- Regional Chemotherapy for CancerAnnals of Surgery, 1960
- Experiences with Isolation-Perfusion Technics in the Treatment of CancerAnnals of Surgery, 1959
- Chemotherapy of CancerAnnals of Surgery, 1958